Theravance Biopharma, Inc.
Sell10.03
Spread0.08
Buy10.11

Trade Theravance Biopharma, Inc. - TBPH stock price

Sell10.03
Spread0.08
Buy10.11
1m
5m
15m
30m
1H
4H
1D
1W
History
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical trials for the treatment of rheumatoid arthritis, myelofibrosis, and ulcerative colitis, as well as for a range of inflammatory intestinal diseases, including ulcerative colitis and Crohn''s disease. In addition, the company''s product portfolio also comprise Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; TD-8236, an investigational, inhaled lung-selective pan-JAK inhibitor, which is Phase II clinical study for treatment of a range of inflammatory diseases; and TD-5202, an investigational, orally administered, gut-selective, irreversible JAK3 inhibitor that is in Phase I clinical study for treatment of inflammatory intestinal diseases. Further, it offers TRELEGY for the treatment of COPD; Velusetrag, an oral and investigational medicine for gastrointestinal motility disorders; and Selective 5-HT4 Agonist for treatment of gastrointestinal motility disorders. It has a licensing and collaboration agreements with Pfizer Inc., Viatris Inc., Janssen Biotech, Inc., Alfasigma S.p.A, and Takeda Pharmaceutical Company Limited. The company was incorporated in 2013 and is based in George Town, the Cayman Islands.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Articles
Hackers drained over $100m across 20 attacks in February, data shows
Jeeves eyes Middle East launch by 2025, CEO hints at Web Summit Qatar 2024
Binance salvages $4b in botched crypto deposits
The potential impact of Bitcoin halving on the cryptocurrency market | Opinion
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

TBPH price history

Date Close Change Chg% Open Min. Max.
2022-09-30 10.03 0.06 0.60 9.97 9.92 10.36
2022-09-30 10.2 0.03 0.29 10.17 10.05 10.41
2022-09-30 10.19 -0.41 -3.87 10.6 10.17 10.95
2022-09-30 10.02 0.04 0.40 9.98 9.72 10.12
2022-09-30 10.0 0.87 9.53 9.13 9.1 10.02
2022-09-30 9.35 0.23 2.52 9.12 9.03 9.37
2022-09-30 9.11 0.05 0.55 9.06 8.99 9.21
2022-09-30 9.23 0.15 1.65 9.08 9.03 9.25
2022-09-30 9.13 0.16 1.78 8.97 8.97 9.38
2022-09-30 9.32 0.00 0.00 9.32 9.23 9.54
2022-09-30 9.43 0.15 1.62 9.28 9.26 9.64
2022-09-30 9.39 0.19 2.07 9.2 9.2 9.52
2022-09-30 9.33 0.24 2.64 9.09 9.01 9.58
2022-09-30 9.35 0.66 7.59 8.69 8.69 9.36
2022-09-30 8.98 0.26 2.98 8.72 8.71 9.12
2022-09-30 8.96 -0.07 -0.78 9.03 8.83 9.14
2022-09-30 9.03 0.23 2.61 8.8 8.8 9.22
2022-09-30 9.0 -0.15 -1.64 9.15 8.92 9.29
2022-09-30 9.26 0.38 4.28 8.88 8.88 9.33
2022-09-30 9.03 0.00 0.00 9.03 8.87 9.18
Go help.dzengi.com